We show that IL-6 loss reduces tumour incidence and metastasis and that ∆122p53 and ∆133p53 upregulate JAK-STAT3 and RhoA-ROCK signalling pathways that contribute to cell migration and invasion. Here, RHOA is linked to neoplasm.